Seminar Programme
To apply for seminars, you need your own ID you get after registration. If you haven’t registered yet, please click the following button.

Pharma IT Seminar

Pharma IT Seminar【4A】

Venue: Seminar Room 4A (East Hall 4)
Capacity: 150 Seats ※Pre Registration required
April 17(Wed.)
4A-04
April 17(Wed.)
13:45-14:15

Limitations of Digital Marketing from a Physician's Perspective and How to Overcome the Barriers

 

Mr. Ryuta Yamashita

Representative of Director

HOKUTO, Inc.


"We combine multiple channels, but the doctors we see are always the same..." "We can get awareness, but we can't move beyond that..."

Have you ever felt these barriers to digital marketing?

A doctor who developed HOKUTO, a medical information application used by one in three physicians in the four years since its release, will explain the causes of and countermeasures against these barriers.

Closed

April 18(Thu.)
4A-10
April 18(Thu.)
12:45-13:30
Ms. Yoshimi Tsuchiya
Mikihiko Nimura, PhD

DX of R&D in the Age of AI - An Evolving Partnership: Innovating Pharmaceutical Safety Research through DX

 

Ms. Yoshimi Tsuchiya

Vice President, 

Medicinal Safety Research Laboratories
Daiichi Sankyo Co., Ltd.

 

Mikihiko Nimura, PhD

Solution Architect

Sales

Enthought G.K.


With the acceleration of digital innovation in the age of AI, a digital-driven approach to drug discovery is essential. In this seminar, we present best practices for defining a strategy to prioritize and achieve DX of R&D and stay competitive.
Enthought is honored to co-host this seminar with Daiichi Sankyo Co., Ltd. for the third consecutive year and welcomes Yumi Tsuchiya, Vice President of the Safety Research Institute, as our speaker. Ms. Tsuchiya will deliver an update on the collaborative development of automatic video analysis of animal behavior and provide insights into how digital technology can contribute to pharmaceutical safety test processes.

Closed

4A-11
April 18(Thu.)
13:45-14:15
Mr. Kazumichi Minato

The latest trends and practical efforts in SaMD (Software as a Medical Device) development and digital biomarker development.

 

Kazumichi Minato

CEO

Representative Director

TechDoctor, Inc.


The utilization of new metrics generated from digital data is anticipated in the future development of therapeutic apps and new treatment solutions. In this lecture, we will introduce efforts to develop diagnostic programs, medical devices, and treatment solutions utilizing digital biomarkers as indicators, constructed through the accumulation and analysis of long-term data obtained from general wearable devices such as Fitbit and Apple Watch, and their implementation in society. Additionally, we will discuss the practical hurdles and challenges faced in the development of Software as a Medical Device (SaMD), along with our company's achievements in this area.

Closed

4A-12
April 18(Thu.)
14:30-15:00
Mr. Hiroki Yamada
Mr. Ryosuke Tsutsui

Marketing Strategies for Specialty Pharmaceuticals Co-Created with Medical Specialists

 

Mr. Hiroki Yamada

CEO

Medii, Inc.

 

Mr. Ryosuke Tsutsui

COO

Medii, Inc.


Specialties, including rare diseases and oncology, pose significant challenges to diagnosis and treatment for physicians in clinical practice due to the less chances of encounters.
The way information is provided to physicians needs an urgent change from the push marketing, assuming that there is always a need for information. In this issue, we will introduce the actual situation and challenges from the physiciansʼ viewpoint, and Mediiʼs effective approaches and achievements in this area.

FREE
Full

4A-13
April 18(Thu.)
15:15-15:45
Ms. Mizue Haga
Mr. Nishiuma Shinichi
Mr. Kumagai Takuya

Data Utilization and Analytical Approaches in KOL Targeting:

The key to getting off to a good start when entering a new line of business

Ms. Mizue Haga

Account Management Unit

Pharma Information Network Inc.

 

Mr. Nishiuma Shinichi

Medical Division

Aculys Pharma, Inc.

 

Mr. Kumagai Takuya

Medical Division

Aculys Pharma, Inc.

 


It is important for pharmaceutical companies to find KOLs based on objective viewpoint more quickly and with fewer resources when entering a new field, to concentrate on communication with physicians. In this seminar, we will invite Aculys Pharma, Inc. as a lecturer that they introduce actual examples of KOL targeting using data and its effectiveness.

FREE
Full

April 19(Fri.)
4A-15
April 19(Fri.)
10:15-11:00

Digital Transformation (DX): Recent Advancements and Future Outlook

 

Mr. Kazumitsu Kanatani
Head of Digital Strategy Dept.
Digital Strategy Department, Digital Transformation Unit
Chugai Pharmaceutical Co., Ltd.


The movement towards digital transformation (DX) in the healthcare industry is accelerating. Chugai Pharmaceutical is promoting DX by establishing the "CHUGAI DIGITAL VISION 2030" and formulating three strategies for its realization: "Innovative drug discovery utilizing digital technology," "Efficiency improvement across all value chains," and "Strengthening digital infrastructure." In this presentation, we will introduce our efforts with specific examples.

FREE
Full

4A-18
April 19(Fri.)
13:45-14:15

The current state and future prospects of real-world data curation and utilization in oncology care in Japan

 

Ms. Eri Tajima 

Head

Strategic Partnerships

Flatiron Health K.K.


The construction and utilization of real-world data (RWD) in the oncology space has been gaining traction globally, as part of concerted efforts to bring effective treatments to patients more efficiently. In Japan, too, there is a crucial need for fit-for-purpose RWD to enhance oncology care and research.

 

Flatiron Health has been constructing electronic health record (EHR)-based RWD in oncology for over 10 years in the U.S., and has contributed to the improvement of cancer care with evidence generated through RWD analysis. Flatiron Health RWD have been utilized widely for the analysis of various real-world clinical outcomes that further inform improved targeted therapies based on genetic mutations and other factors, supporting academic and pharmaceutical research, drug development and regulatory decision-making by authorities.

 

In Japan, electronic health records-based longitudinal, patient-level RWD in Japan is being curated by Flatiron Health K.K., by leveraging both structured and unstructured data processing methodologies established in the US and tailoring the approach to the local clinical context as well as legal, regulatory and ethical requirements. In this presentation, we will introduce our RWD initiatives in Japan, as well as discuss the future prospects for oncology RWD in Japan.

FREE
Full

4A-19
April 19(Fri.)
14:30-15:00

Initiatives for Patient Registry Services and Expansion to New Healthcare Services using Hitachi's Proprietary Concealment ~Secure Personal Information Management~

 

Keiichi Sato Ph.D., PMP

Senior Engineer

Public Safety Department2, Public Safety Promotion Operation,  Government & Public Corporation Information System Division

Hitachi, Ltd.


The utilization of patient information and the development of new healthcare services are major themes for pharmaceutical companies, but there’s also, a necessity to contend with strict personal information management. In this presentation, we will introduce secure and safepersonal information management using Hitachi's proprietary concealment and pseudonymization technologies, the efforts of patient registries services, and the development of new healthcare services.

FREE

Register
4A-20
April 19(Fri.)
15:15-15:45
Mr. Atsushi Ito
Mr. Takashi Aida

AI Chatbots, Generative AI, and Online Events: Present and Future Possibilities

 

Mr. Atsushi Ito

Medical Sales Department, Sales Division

KIMURA INFORMATION TECHNOLOGY Co., Ltd.

 

Mr. Takashi Aida

 

Event Sales Department, Sales Division 

KIMURA INFORMATION TECHNOLOGY Co., Ltd.


No.1 of web lecture results in the medical field.

Kimura Information Technology, a No.1 of AI implementation results in call centers/inquiry support for manufacturing companies.

We are going to provide you with information on the "generation AI" and "on-line events" that we are currently working on, including the present and future concepts.

FREE
Full

Pharma IT Seminar【4B】

Venue: Seminar Room 4B (East Hall 4)
Capacity: 100 Seats ※Pre Registration required
April 17(Wed.)
4B-02
April 17(Wed.)
11:40-12:40
Consecutive interpretation
Mr. Alan Thomas

Technology Driving Change and Opportunity in Japan Pharmaceutical Market – from Clinical to Manufacturing to Commercialization.

IQVIA Solutions Japan G.K.

Strategy & Corporate Development

Sr Dir, Strategic Planning

Mr. Alan Thomas


“Technology Driving Change and Opportunity in the Japan Pharmaceutical Market – from Clinical to Manufacturing to Commercialization” – Technology continues to drive healthcare forward, providing advancement in all stages of pharmaceutical development and commercialization, ultimately providing improved patient access to medicines and improved patient outcomes. Join IQVIA Japan as we provide an update on the Japan pharmaceutical market, and how technology is shifting the focus of stakeholder activity, and the future outlook of healthcare and pharmaceuticals in Japan

Closed

4B-06
April 17(Wed.)
15:15-15:45

AI drug discovery support solution specializing in hypothesis generation

 

Mr. Hiroyoshi Toyoshiba

Executive Officer CTO, Drug Discovery AI Factory Executive Officer, Doctor of Science
Life Science AI Business Division and Behavior Informatics Laboratories

FRONTEO, Inc.
 


At Drug Discovery AI Factory, biologists with extensive drug discovery experience cultivated at major pharmaceutical companies and international research institutions, as well as a deep understanding of AI, utilize proprietary natural language processing AI to propose multiple highly novel target genes and their hypothesis generation in a short period of time using a unique analysis method. We will introduce our support for significant streamline, accelerate, and improve the probability of success in drug discovery research.

Closed

April 18(Thu.)
4B-12
April 18(Thu.)
14:30-15:00

Introduction to Causaly and how Causaly can help accelerate your R&D productivity

 

Mr. Kojiro Ide

Product Manager

Product Management, Research Support Division

USACO Corporation


Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Sciences research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies. This session will focus on an overview of Causaly, and how Causaly’s platform can be used to accelerate discovery and de-risk preclinical programs.

FREE

Register
4B-14
April 18(Thu.)
16:00-16:45
Mr. Miura Hirokazu

Promoting digital transformation (DX) at pharmaceutical plant

Mr.Miura Hirokazu
Quality control department, Takasaki Quality Unit, Quality Division
Kyowa Kirin Co., Ltd.

Mr.Toshikazu Kobayashi
Manager 
Laboratory Informatics Sales Department

Agilent Technologies Japan, Ltd


Kyowa Kirin Company, Limited is promoting Digital Transformation (DX) to enhance corporate competitiveness and to support the continuous development of its business. We are also promoting DX in quality control in the field of GMP. In this presentation, we will introduce our current efforts and future developments, including the introduction of the latest robot technology, as well as examples of DX promotion in quality control operations at our Takasaki Plant.

Agilent Technologies Japan, Ltd. will introduce our OpenLab software, which promotes digital technology in quality control.

 

FREE
Full

Pharma IT Seminar【4S】

Venue: Seminar Room 4S (East Hall 4)
Capacity: 40 Seats ※Pre Registration required
April 17(Wed.)
4S-01
April 17(Wed.)
10:30-11:00

Introducing XAI “B3” that contributes to identify the mechanisms of diseases and treatments

 

Mr. Shota Nemoto

Engineer

Industrial Digital Business Unit Enterprise Solutions Division

Hitachi, Ltd.


We have developed an XAI analysis technology called “B3 (Black Box Breaker)” that offers accurate analysis result and can explain result evidence.

We will introduce the overview of cloud-based B3 Analytics as well as its case studies.

Closed

4S-02
April 17(Wed.)
11:30-12:00

Learn about the latest trends in pharmaceutical marketing from Medinew's featured article.

 

Mr. Shogo Ogawa

Account Planner

Account Management Unit


Medinew, a medical marketing magazine operated by Iyaku Joho Net, writes over 140 articles a year. In this seminar, we will introduce some of the most popular articles in Medinew recently and explain what kind of marketing information pharmaceutical companies are paying attention to. If you are interested in understanding the latest trends in pharmaceutical marketing and the needs of the industry, please join us.

 

Closed

4S-05
April 17(Wed.)
15:00-15:30
Mr. Hiroomi HAYASHI
Me. Masashi Kaneko
Mr. Ryunosuke MISAWA

Knock on the Door and Mitsubishi Tanabe Pharma create new patient support 

- Nanacara", a new support system for pharmaceutical companies created by listening to and empathizing with patients and their families. -

 

Mr. Hiroomi HAYASHI

CEO(Chief Executive Officer)

KNOCK ON THE DOOR Inc.

 

Mr. Masashi KANEKO
Vice President,Head of Digital Transformation
Mitsubishi Tanabe Pharma Corporation


Mr. Ryunosuke MISAWA


Nanacara has become one of the most popular PHR solutions in the epilepsy field as a result of listening to the voices of patients and families with intractable diseases, identifying challenges together with companies, forming a problem-solving team, and creating a solution. We will show you how our successful method can solve the challenges surrounding pharmaceutical companies.

Closed

4S-06
April 17(Wed.)
16:00-16:30

Information Extraction from Specialized Documents Using Generative AI

 

Mr. Ryota Yamada

CEO

fuku, Inc.


Our company specializes in natural language processing and life science databases, developing resources like rare disease ontologies, AI drug discovery learning data, and experimental condition databases. In this seminar, we will share case studies on extracting information from academic papers and assessment reports using generative AI. We will also discuss the challenges encountered when integrating these technologies into business operations and the strategies to overcome them.

 

Closed

April 19(Fri.)
4S-15
April 19(Fri.)
10:30-11:00
Mr. Takusuke Fujii
Mr. Mirle Seetharamu Manjunath

Generative AI x Manufacturing Execution System – “Apprentice Tempo MES" is increasingly adopted in Japan

Supported by Tata Consultancy Services

Apprentice

Customer Success Department

Project Manager

Mr. Takusuke Fujii

 

Tata Consultancy Services Japan Ltd.

IoT & Digital Engineering

Director

Mr. Mirle Seetharamu Manjunath


DX by conventional manufacturing execution systems has been limited to local optimization within the entire drug manufacturing value chain. The cGMP-compliant, cloud-native manufacturing execution system offers a holistic approach, providing enterprise-level visibility, accelerated product pipeline, collaboration with external partners, and the utilization of AI.

FREE

Register
Almost Full
4S-16
April 19(Fri.)
11:30-12:00
Mr. Masashi KANEKO
Mr. Masashi KANEKO
Mr. Ryunosuke MISAWA

Knock on the Door and Mitsubishi Tanabe Pharma create new patient support 

- Nanacara", a new support system for pharmaceutical companies created by listening to and empathizing with patients and their families. -

 

Mr. Hiroomi HAYASHI

CEO(Chief Executive Officer)

KNOCK ON THE DOOR Inc.

 

Mr. Masashi KANEKO
Vice President,Head of Digital Transformation
Mitsubishi Tanabe Pharma Corporation


Mr. Ryunosuke MISAWA


Nanacara has become one of the most popular PHR solutions in the epilepsy field as a result of listening to the voices of patients and families with intractable diseases, identifying challenges together with companies, forming a problem-solving team, and creating a solution. We will show you how our successful method can solve the challenges surrounding pharmaceutical companies.

FREE
Full

4S-19
April 19(Fri.)
14:45-15:15

Passing on the Pharmaceutical Industry's Technology / Connecting the Skills of Experts to the Future

Scientific Methods to Turn Tacit Knowledge into Formal Knowledge

 

Ms RIE YABUYA

Manager

Consulting Dept R&D Center

DENTSU SOKEN INC.


Is the know-how cultivated through years of experience in pharmaceutical plants, R&D, testing, sales, etc. in a form that is easy for everyone to use? The evolution of technology is remarkable, and good quality data is a prerequisite for creating a strong AI. Functional Approach (FA) realizes extraction/consulting of high quality tacit knowledge that is ingrained in the bodies of skilled professionals. *FA: Presented by the Japanese Society for Artificial Intelligence

FREE
Full

4S-20
April 19(Fri.)
15:30-16:00

Activating Conference Engagement with VR/AR:  Demo with VR goggles are included

 

Mr. Yuuki Hono

XR Specialist

Sales Department

Bigm2y., Co.Ltd


As conferences transition from remote to offline, many companies are eager to enhance the appeal of their events. In this session, Bigm2y will introduce solutions that utilize VR in conferences, pioneering new ways to captivate attendees and ensure their satisfaction.

 

FREE

Register
Almost Full
4S-21
April 19(Fri.)
16:15-16:45

Case Studies on Disease Awareness along the Patient Journey - Collaborative Project with Pharmaceutical and Medical Device Companies Utilizing the "Ishamachi Hospital Search Service" -.

 

Mr. Haruto Shiroma

CEO / Founder

Mediwill Inc.


We will be presenting on disease awareness projects along the Patient Journey. Case studies of digital marketing solutions utilizing the "Ishamachi Hospital Search Service" to connect undiagnosed patients to appropriate hospitals, including Asahi Kasei Pharma's "Honeken", Kyowa Kirin's "Kurukotsu Hiroba", and Medicon's "Sokei Hernia Note".

 

FREE
Full

 

Recommended browser is Google Chrome.
Page Top
Loading...